iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Syngene International signs 10-year deal with Zoetis

19 Jul 2022 , 01:34 AM

Syngene International today announced the signing of a 10- year agreement with leading animal health company Zoetis to manufacture the drug substance for Librela bedinvetmab a first in class monoclonal antibody used for treating osteoarthritis in dogs Launched in Europe the UK and Switzerland the product won Best new companion animal product by IHS Markit Connect in 2021 for its transformational impact on pain relief for canines suffering from this debilitating condition Syngenes collaboration with Zoetis started in 2011 Over the past 11 years Syngene has undertaken development work on several monoclonal antibodies for use in animal health including developing and manufacturing clinical supplies of a treatment for allergic or atopic dermatitis now widely used and Librela This agreement initially centred on Librela paves the way for development and manufacturing of other molecules in the coming years and is expected to be worth up to US$ 500 Mn to Syngene over 10 years subject to regulatory approvals and market demand

Related Tags

  • Announcements
  • BSE
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.